Other Relevant News

Canada Will Let Terminally Ill Patients Use Psychedelic Mushrooms For End-Of-Life Care

CNN, August 6, 2020

Four cancer patients in end-of-life care will be become the first people in decades to legally possess and consume psilocybin mushrooms in Canada after a landmark decision.

The Current Status of Psychedelics in Psychiatry

Dr David Nutt and Dr Robin Carhart-Harris, American Medical Association, July 29, 2020

Download the article here as PDF.

Psilocybin & OCD: Can psychedelics treat obsessive compulsive disorder?

New Atlas, July 23, 2020

A new review from neuroethicist Eddie Jacobs, and published in the Journal of Psychedelic Studies, is suggesting psilocybin may have great potential as a treatment for obsessive-compulsive disorder (OCD).

Lucy in the sky with diamonds

Vogue, July 20, 2020

LSD, psilocybin, ecstasy, ayahuasca. From happy trips of the past to mental health of the present, could psychedelics be the future of therapy?

Magic mushrooms could help ex-soldiers to overcome trauma

The Guardian, July 4, 2020

As more troops self-medicate with psychedelic drugs to help with PTSD, a group of experts lobby for proper clinical trials.

We can no longer ignore the potential of psychedelic drugs to treat depression

Dr Robin Carhart-Harris, The Guardian, June 8, 2020

Imperial College, UK have been comparing psilocybin to conventional antidepressants – and the results are likely to be game-changing

Dr Robin Carhart-Harris is a member of the Mind Medicine Australia advisory panel.

COVID-19 impact likely to lead to increased rates of suicide and mental health

Dr Tony Bartone, Professor Ian Hickie AM, Professor Patrick McGorry AO, AMA Joint Statement, June 2, 2020

Australia will likely see increases in youth suicide and a surge in demand for specialist mental health services as the full and lasting impact of the COVID-19 pandemic is experienced across the community.

Psychedelics v. Cannabis: In Search of a Better Business Plan

David H., The Cannabis Investor, May 27, 2020

Organizations forming today will build the infrastructure which, three to five years from now, will be delivering psychedelic medicines to the world.

Interim Analysis Shows At Least 90% Chance of Statistically Significant Difference in PTSD Symptoms after MDMA-assisted Psychotherapy

Brad Burge, Multidisciplinary Association for Psychedelic Studies (MAPS), May 13, 2020

Results are the strongest confirmation that an interim analysis can provide

German Government Funds Psilocybin Study for Depression

Mind and Brain Institute, April, 2020

Move over, pot: Psychedelic companies are about to go public

Kristine Owram, Bloomberg News, February 11, 2020

Psychedelics Create New Communication Pathways In The Brain ( Homological Scaffolds )

Beckley Foundation, November 17, 2017

Watch our brains become more connected on psilocybin, and learn how psychedelics can help treat conditions such as depression, addiction, and PTSD.

The future of psychedelic science: What the next decade holds

Rich Haridy, New Atlas, December 26, 2019

The Return Trip: Psychedelics may come back from the abyss of illegality

Peter Stilla, Valley Advocate, November 20, 2019

Psilocybin-assisted therapy for depression: How do we advance the field?

David Castle, Australian & New Zealand Journal of Psychiatry, November 19, 2019

Magic mushroom compound psilocybin shows promise for treatment of anxiety and depression

Robyn Williams, The Science Show, ABC Radio National, November 11, 2019

Health Report with Norman Swan

Dr Norman Swan, On Breakfast Program with Hamish Macdonald, ABC Radio National, November 11, 2019

Research into psychedelic drugs like LSD is growing, encouraged by positive early trials. Scientists think these drugs could treat things like post-traumatic stress disorder and depression.

Download the interview here as an mp3.

What Happened When I Sought Alternative Mental Health Treatment Abroad

Lizbeth Finn-Arnold, The Mighty, November 11, 2019

Why Psychedelics Could be the Future of Anorexia Treatment

Tessa Love, Elemental Medium, November 6, 2019

Tim Ferris, the man who put his money behind psychedelic medicine

Benedict Carey, The New York Times, September 9, 2019

John Hopkins opens new center for Psychedelic Research

Benedict Carey, The New York Times, September 5, 2019

Israel seeks to beat PTSD with ‘ecstasy’ therapy

Jonah Mandel, The Times of Isreal, August 21, 2019

MDMA, Or Ecstasy, Shows Promise As A PTSD Treatment

Will Stone, WAMU 88.5 American University Radio, June 13, 2019

'These are healing plants': Oakland decriminalizes magic mushrooms

Sam Levin, The Guardian, June 5, 2019
Yesterday Oakland became the second city in the US to decriminalize magic mushrooms and other psychedelics.

Denver Voters Support ‘Magic’ Mushrooms

By Patricia Mazzei, The New York Times, May 8, 2019

1 in 8 (over 3 million) Australians are on antidepressants - Why is the Lucky Country so miserable?

By Dr Martin Whitely and Dr Melissa Raven, PsychWatch Australia, February 10, 2019

Israel approves compassionate use of MDMA to treat PTSD

Science & Health - Haaretz.com, February 10, 2019

Denver could become the first US city to decriminalize magic mushrooms

By Mallory Hughes and Jacqueline Howard, CNN. Updated 2102 GMT (0502 HKT) January 9, 2019

MDMA—its potential therapeutic use podcast extra

All in the Mind, ABC Radio National, September 10, 2018

Turn on, tune in

All in the Mind, ABC Radio National, September 9, 2018

Finding Peace With the Fact I Would Die

Nick Fernandez, Medium, May 30, 2018

Podcast extra - MDMA and its potential therapeutic use

All in the Mind, ABC Radio National, March 22, 2018

Johns Hopkins and NYU studies in psilocybin as a treatment for cancer-related psychological distress. ​

News outlets included CNNNew York Times, NewsweekPBS NewshourScienceScientific AmericanThe AtlanticThe GuardianTimeand USA Todayamong others.
Two clinical studies (released Dec. 1, 2016) examining the effect of psilocybin on symptoms of depression and anxiety in people with life-threatening cancer were released and covered by a number of media.

“The fascinating, strange medical potential of psychedelic drugs, explained in 50+ studies"

Vox June 27, 2016
Show Me the Evidence staff examines more than 50 studies analyzing the safety and efficacy of psychedelic drugs and psychedelic-assisted therapy and interviews researchers involved in the work. Vox, 2016

"Magic-mushroom drug lifts depression in first human trial"

Zoe Cormier, Nature, May 17, 2016
Imperial College study provides preliminary support for the safety and efficacy of psilocybin as a therapy for treatment-resistant depression. Nature, 2016

“Psilocybin can reduce the pain of social exclusion”

Douglas Main, Newsweek, April 19, 2016
Researchers at the University of Zurich show that a small amount of psilocybin can reduce the distress caused by mild social exclusion and lessens activity in the area of the brain associated with this emotion. Newsweek, 2016

“Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA”

The Lancet Psychiatry, April 5, 2016
Drug-assisted psychotherapy as a possible alternative to existing pharmacological and psychological treatments. (Free registration required)

“Professor Probes Psychedelic Drugs for a Cure to Nicotine Addiction”

Washingtonian, January 7, 2014
Recent John’s Hopkins study on effecting addictive behaviour with psychedelics. Washingtonian, 2014

Close Menu